Rivaroxaban and apixaban are Factor Xa (FXa) inhibitor oral anticoagulants that are used to treat and prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, deep vein thrombosis and pulmonary embolism. Here, F10 is linked to stroke disorder.